Literature DB >> 18602995

An integrated science-based approach to drug development.

Paul Whi Parren, Jan G J van de Winkel.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18602995     DOI： 10.1016/j.coi.2008.06.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


× No keyword cloud information.
  6 in total

1.  Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients.

Authors:  Frank J Beurskens; Margaret A Lindorfer; Mohammed Farooqui; Paul V Beum; Patrick Engelberts; Wendy J M Mackus; Paul W H I Parren; Adrian Wiestner; Ronald P Taylor
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

2.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

Review 3.  Therapeutic antibodies for autoimmunity and inflammation.

Authors:  Andrew C Chan; Paul J Carter
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

4.  A novel monoclonal antibody associated with glucoside kills gastric adenocarcinoma AGS cells based on glycosylation target.

Authors:  Heng Xu; Boying Dun; Beiyi Liu; David Mysona; Jin-Xiong She; Rong Ma
Journal:  J Cell Mol Med       Date:  2022-08-09       Impact factor: 5.295

5.  Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.

Authors:  Anchal Ghai; Dolonchampa Maji; Nicholas Cho; Chantiya Chanswangphuwana; Michael Rettig; Duanwen Shen; John DiPersio; Walter Akers; Farrokh Dehdashti; Samuel Achilefu; Ravi Vij; Monica Shokeen
Journal:  J Nucl Med       Date:  2017-10-12       Impact factor: 10.057

6.  Development of Doxorubicin-Loaded Magnetic Silica-Pluronic F-127 Nanocarriers Conjugated with Transferrin for Treating Glioblastoma across the Blood-Brain Barrier Using an in Vitro Model.

Authors:  Geetha B Heggannavar; Chinmay G Hiremath; Divya D Achari; Vishwas G Pangarkar; Mahadevappa Y Kariduraganavar
Journal:  ACS Omega       Date:  2018-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.